MARCH 9, 2017: CANCER FORUM/MUSCULOSKELETAL RESEARCH GROUP TUMOR BOARD PRESENTATION AT UCLA

Cancer Forum/Musculoskeletal Research Group Tumor Board presentation at UCLA

 

  “Tumor Grade & Neoadjuvant Therapy Impact The Establishment of Soft-Tissue Sarcoma Patient-Derived Orthotopic Xenografts (PDOX): A UCLA Sarcoma Program Prospective Clinical Trial”

By Tara Russell, M.D.
Research Follow/Surgical Resident
UCLA Department of Surgical Oncology
3:30 p.m., SM UCLA Conference Room #3
Objective: Feasibility of Personalized Oncology Care in Sarcoma Patients (CME credit)

Comments are closed.